Vernalis shares slide after latest FDA rejectionShares in UK pharma Vernalis slid more than 15% after the US regulator rejected its cough and cold Share XVernalis shares slide after latest FDA rejectionhttps://pharmaphorum.com/news/vernalis-shares-slide-latest-fda-rejection/
